CYP11B1
CYP11B1 (cytochrome P450 family 11 subfamily B member 1, also known as P450C11, FHI, CPN1 and CYP11B) is a mitochondrial cytochrome P450 monooxygenase that carries out 11-beta hydroxylation in the biosynthesis of adrenal corticoids, including cortisol and corticosterone. Browse Assay Genie's current range of CYP11B1 research reagents below, or read on for the biology behind the target.
CYP11B1 is a cytochrome P450 monooxygenase mainly involved in the biosynthesis of adrenal corticoids. It is a steroid 11-beta, 18- and 19-hydroxylase, with preferred regioselectivity at the 11-beta position, then 18, and lastly 19. It hydroxylates 11-deoxycortisol and 11-deoxycorticosterone at the 11-beta position, yielding cortisol and corticosterone respectively. Because it lacks 18-oxidation activity, it cannot produce aldosterone.
Mechanistically, the enzyme uses molecular oxygen, inserting one oxygen atom into the substrate and reducing the second to water. The two electrons required come from NADPH through a two-protein mitochondrial transfer system: the flavoprotein FDXR (adrenodoxin reductase) and the nonheme iron-sulfur protein FDX1 or FDX2 (adrenodoxin). Beyond mineralocorticoid and glucocorticoid synthesis, CYP11B1 can also act in androgen metabolism, converting androst-4-ene-3,17-dione to 11-beta-hydroxyandrost-4-ene-3,17-dione and testosterone to 11-beta,17-beta-dihydroxyandrost-4-ene-3-one.
The CYP11B1 gene belongs to the cytochrome P450 family 11 group, and the protein is localised to the mitochondrial inner membrane. NCBI Gene describes its role in the conversion of progesterone to cortisol in the adrenal cortex, and notes that transcript variants encoding different isoforms exist. Mutations in the gene cause congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency. Earlier names include cytochrome P450, subfamily XIB (steroid 11-beta-hydroxylase), polypeptide 1. A rat ortholog, Cyp11b1, is recorded.
CYP11B1 catalyses the 11-beta hydroxylation steps that yield cortisol and corticosterone, making it a central enzyme for studying adrenal corticoid biosynthesis.
Mutations in the CYP11B1 gene cause congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency, linking the enzyme to inherited disorders of adrenal function.
Activity depends on NADPH, FDXR and FDX1 or FDX2, so CYP11B1 is a useful model for mitochondrial P450 electron transfer systems.
CYP11B1 converts androst-4-ene-3,17-dione and testosterone to their 11-beta-hydroxylated products, connecting it to androgen metabolic pathways.
CYP11B1 is a mitochondrial steroid 11-beta-hydroxylase. It converts 11-deoxycortisol to cortisol and 11-deoxycorticosterone to corticosterone in the adrenal cortex. It also has 18- and 19-hydroxylase activity, but it cannot produce aldosterone because it lacks 18-oxidation activity.
CYP11B1 is also known as P450C11, FHI, CPN1 and CYP11B. Its earlier HGNC name was cytochrome P450, subfamily XIB (steroid 11-beta-hydroxylase), polypeptide 1. NCBI Gene notes that transcript variants encoding different isoforms have been described.
Mutations in the CYP11B1 gene cause congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency. A rat ortholog, Cyp11b1, is recorded; check the datasheet of any product for its validated reactivity.
Other cytochrome P450 enzymes involved in steroid, sterol and vitamin D metabolism with products at Assay Genie.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P15538; product specifications from Assay Genie datasheets.